Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 65.16%
March 31, 2026 60.81%
December 31, 2025 73.16%
September 30, 2025 60.02%
June 30, 2025 59.67%
March 31, 2025 56.98%
December 31, 2024 61.53%
September 30, 2024 67.80%
June 30, 2024 57.54%
March 31, 2024 55.33%
December 31, 2023 55.06%
September 30, 2023 56.92%
June 30, 2023 52.96%
March 31, 2023 56.50%
December 31, 2022 52.70%
September 30, 2022 72.33%
June 30, 2022 61.16%
March 31, 2022 60.79%
December 31, 2021 55.55%
September 30, 2021 54.21%
June 30, 2021 60.93%
March 31, 2021 57.31%
December 31, 2020 54.74%
September 30, 2020 58.01%
June 30, 2020 65.30%
Date Value
March 31, 2020 62.56%
December 31, 2019 58.83%
September 30, 2019 62.43%
June 30, 2019 59.67%
March 31, 2019 59.92%
December 31, 2018 61.43%
September 30, 2018 55.28%
June 30, 2018 63.47%
March 31, 2018 60.52%
December 31, 2017 60.51%
September 30, 2017 53.62%
June 30, 2017 60.53%
March 31, 2017 63.20%
December 31, 2016 59.56%
September 30, 2016 58.66%
June 30, 2016 63.60%
March 31, 2016 60.99%
December 31, 2015 52.10%
September 30, 2015 55.96%
June 30, 2015 62.94%
March 31, 2015 64.83%
December 31, 2014 58.40%
September 30, 2014 57.95%
June 30, 2014 64.04%
March 31, 2014 60.90%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
AstraZeneca PLC 76.09%
ANI Pharmaceuticals, Inc. 54.97%
Corcept Therapeutics, Inc. 98.41%
Veru, Inc. --
Avadel Pharmaceuticals Plc --

Gross Profit Margin (Quarterly) Related Metrics